Abstract:Delay in the assessment of tumor response to radiotherapy continues to pose a major challenge to quality of life for patients with nonresponsive tumors. Here, we exploited label-free Raman spectroscopic mapping to elucidate radiation-induced biomolecular changes in tumors and uncovered latent microenvironmental differences between treatment-resistant and -sensitive tumors. We used isogenic radiation-resistant and -sensitive A549 human lung cancer cells and human head and neck squamous cell carcinoma (HNSCC) cell lines (UM-SCC-47 and UM-SCC-22B, respectively) to grow tumor xenografts in athymic nude mice and demonstrated the molecular specificity and quantitative nature of Raman spectroscopic tissue assessments. Raman spectra obtained from untreated and treated tumors were subjected to chemometric analysis using multivariate curve resolution-alternating least squares (MCR-ALS) and support vector machine (SVM) to quantify biomolecular differences in the tumor microenvironment. The Raman measurements revealed significant and reliable differences in lipid and collagen content postradiation in the tumor microenvironment, with consistently greater changes observed in the radiation-sensitive tumors. In addition to accurately evaluating tumor response to therapy, the combination of Raman spectral markers potentially offers a route to predicting response in untreated tumors prior to commencing treatment. Combined with its noninvasive nature, our findings provide a rationale for in vivo studies using Raman spectroscopy, with the ultimate goal of clinical translation for patient stratification and guiding adaptation of radiotherapy during the course of treatment. SIGNIFICANCE: These findings highlight the sensitivity of label-free Raman spectroscopy to changes induced by radiotherapy and indicate the potential to predict radiation resistance prior to commencing therapy.

Raman spectroscopy detects melanoma and the tissue surrounding melanoma using tissue-engineered melanoma models

Raman-Spectroscopic Characterization of Human-Malignant Tissues - Implications for A Percutaneous Optical Biopsy Technique for In-Situ Tissue Diagnosis

Detection of Melanin Influence on Skin Samples Based on Raman Spectroscopy and Optical Coherence Tomography Dual‐modal Approach

Detecting Temporal and Spatial Effects of Epithelial Cancers with Raman Spectroscopy

Raman Spectroscopy Combined with Deep Learning for Rapid Detection of Melanoma at the Single Cell Level.

Raman Spectral Imaging Based Histopathology of Human Skin Tissue

Accuracy of Raman Spectroscopy for Differentiating Skin Cancer from Normal Tissue

Raman spectroscopy for classification of neoplastic and non-neoplastic CAM colon tumors

Evaluation of Human Melanoma and Normal Formalin Paraffin-Fixed Samples Using Raman and LIBS Fused Data

A Pilot Study for Distinguishing Basal Cell Carcinoma from Normal Human Skin Tissues Using Visible Resonance Raman Spectroscopy

Utilizing Raman Spectral Imaging for distinguishing breast cancer from hyperplasia

Investigation on the Cancer Invasion and Metastasis of Skin Squamous Cell Carcinoma by Raman Spectroscopy

Resonance Raman spectroscopy for human cancer detection of key molecules with clinical diagnosis

Raman Spectra Exploring Breast Tissues: Comparison Of Principal Component Analysis And Support Vector Machine-Recursive Feature Elimination

Label-Free Raman Spectroscopy Reveals Signatures of Radiation Resistance in the Tumor Microenvironment

Raman Spectroscopy and Cancer Diagnosis

Combining fiber optical tweezers and Raman spectroscopy for rapid identification of melanoma.

Diagnosing molecular subtypes of breast cancer by means of Raman spectroscopy

Raman Spectroscopic Characterization of Human Breast Tissues: Implications for Breast Cancer Diagnosis

Studies on Human Breast Cancer Tissues with Raman Microspectroscopy

Resonance Raman imaging for detecting and monitoring molecular pathological changes in human brain tumors related to Warburg effect